Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

V. Saraswat; S. Norris; R. J. De Knegt; J. F. Sanchez Avila; M. Sonderup; E. Zuckerman; P. Arkkila; C. Stedman; S. Acharya; I. Aho; A. C. Anand; M. I. Andersson; V. Arendt; O. Baatarkhuu; K. Barclay; Z. Ben-Ari; C. Bergin; F. Bessone; S. Blach; N. Blokhina; C. R. Brunton; G. Choudhuri; V. Chulanov; L. Cisneros; E. A. Croes; Y. A. Dahgwahdorj; O. Dalgard; J. R. Daruich; N. R. Dashdorj; D. Davaadorj; M. De Vree; C. Estes; R. Flisiak; A. C. Gadano; E. Gane; W. Halota; A. Hatzakis; C. Henderson; P. Hoffmann; J. Hornell; D. Houlihan; S. Hrusovsky; P. Jarčuška; D. Kershenobich; K. Kostrzewska; P. Kristian; M. Leshno; Y. Lurie; A. Mahomed; N. Mamonova; N. Mendez-Sanchez; J. Mossong; E. Nurmukhametova; P. Nymadawa; M. Oltman; J. Oyunbileg; Ts Oyunsuren; G. Papatheodoridis; N. Pimenov; N. Prabdial-Sing; M. Prins; P. Puri; S. Radke; A. Rakhmanova; H. Razavi; K. Razavi-Shearer; H. W. Reesink; E. Ridruejo; R. Safadi; O. Sagalova; R. Sanduijav; I. Schréter; C. Seguin-Devaux; S. R. Shah; I. Shestakova; A. Shevaldin; O. Shibolet; S. Sokolov; K. Souliotis; C. W. Spearman; T. Staub; E. A. Strebkova; D. Struck; K. Tomasiewicz; L. Undram; A. J. Van Der Meer; D. Van Santen; I. Veldhuijzen; F. G. Villamil; S. Willemse; F. R. Zuure; M. O. Silva; V. Sypsa; E. Gower

doi:10.1111/jvh.12350

Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

V. Saraswat^*
, S. Norris
, R. J. De Knegt
, J. F. Sanchez Avila
, M. Sonderup
, E. Zuckerman
, P. Arkkila
, C. Stedman
, S. Acharya
, I. Aho
, A. C. Anand
, M. I. Andersson
, V. Arendt
, O. Baatarkhuu
, K. Barclay
, Z. Ben-Ari
, C. Bergin
, F. Bessone
, S. Blach
, N. Blokhina

C. R. Brunton, G. Choudhuri, V. Chulanov, L. Cisneros, E. A. Croes, Y. A. Dahgwahdorj, O. Dalgard, J. R. Daruich, N. R. Dashdorj, D. Davaadorj, M. De Vree, C. Estes, R. Flisiak, A. C. Gadano, E. Gane, W. Halota, A. Hatzakis, C. Henderson, P. Hoffmann, J. Hornell, D. Houlihan, S. Hrusovsky, P. Jarčuška, D. Kershenobich, K. Kostrzewska, P. Kristian, M. Leshno, Y. Lurie, A. Mahomed, N. Mamonova, N. Mendez-Sanchez, J. Mossong, E. Nurmukhametova, P. Nymadawa, M. Oltman, J. Oyunbileg, Ts Oyunsuren, G. Papatheodoridis, N. Pimenov, N. Prabdial-Sing, M. Prins, P. Puri, S. Radke, A. Rakhmanova, H. Razavi, K. Razavi-Shearer, H. W. Reesink, E. Ridruejo, R. Safadi, O. Sagalova, R. Sanduijav, I. Schréter, C. Seguin-Devaux, S. R. Shah, I. Shestakova, A. Shevaldin, O. Shibolet, S. Sokolov, K. Souliotis, C. W. Spearman, T. Staub, E. A. Strebkova, D. Struck, K. Tomasiewicz, L. Undram, A. J. Van Der Meer, D. Van Santen, I. Veldhuijzen, F. G. Villamil, S. Willemse, F. R. Zuure, M. O. Silva, V. Sypsa, E. Gower

^*Corresponding author for this work

Sanjay Gandhi Postgraduate Institute of Medical Sciences
St James's Hospital
Erasmus University Rotterdam
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
University of Cape Town
Technion-Israel Institute of Technology
Helsinki University Hospital
University of Otago
All India Institute of Medical Sciences, New Delhi
Apollo Hospitals Group
Stellenbosch University
Center Hospitalier de Luxembourg
Mongolian National University of Medical Sciences
Hepatitis Foundation of New Zealand
Trinity College Dublin
Universidad Nacional de Rosario
Center for Disease Analysis
Hospital of Infectious Diseases #1
Canterbury District Health Board
Department of Gastroenterology and Hepato-Biliary Sciences, Fortis Memorial Research Institute
Central Research Institute of Epidemiology
Instituto Mexicano del Seguro Social
Trimbos Institute, Netherlands Institute of Mental Health and Addiction
University of Oslo
Universidad de Buenos Aires
Onom Foundation
University of Groningen
Medical University of Białystok
Hospital Italiano de Buenos Aires
Auckland District Health Board
Department of Infectious Diseases and Hepatology, CMUMK Bydgoszcz
National and Kapodistrian University of Athens
New Zealand Needle Exchange Programme
Health Directorate
University College Dublin
Slovak Medical University
Medical Faculty
Pavol Jozef Šafárik University
HTA Consulting
Shaare Zedek Medical Center
University of the Witwatersrand
Clinical Diagnostics and Research Center
Fundación Clínica Médica Sur
Laboratoire National de Santé
Mongolian Academy of Medical Sciences
Gastroenterology and Hepatology Center
Ministry of Health
Mongolian Academy of Sciences
National Health Laboratory Services
Municipal Health Service of Amsterdam
Academic Medical Centre
Army Hospital Research and Referral
ESR
The University of Auckland
St. Petersburg City AIDS Center
Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno
Hadassah University Medical Centre
South Ural State Medical University
Luxembourg Institute of Health
Global Hospitals
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Ministry of Health
Department of Infectious and Parasitic Diseases with Immunoprophylaxis, St. Petersburg Polyclinic 74
Tel Aviv Sourasky Medical Center
Tyumen Regional State Autonomous Healthcare Institution Consulting and Diagnostic Centre
University of Peloponnese
Samara State Medical University
Medical University of Lublin
Universidad Austral
Division of Infectious Disease Control
Hospital Británico de Buenos Aires

Research output: Contribution to journal › Article › peer-review

90 Scopus citations

Abstract

Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.

Original language	English
Pages (from-to)	6-25
Number of pages	20
Journal	Journal of Viral Hepatitis
Volume	22
Issue number	s1
DOIs	https://doi.org/10.1111/jvh.12350
State	Published - 1 Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HCV
diagnosis
disease burden
epidemiology
hepatitis C
incidence
mortality
prevalence
treatment

Access to Document

10.1111/jvh.12350

Cite this

Saraswat, V., Norris, S., De Knegt, R. J., Sanchez Avila, J. F., Sonderup, M., Zuckerman, E., Arkkila, P., Stedman, C., Acharya, S., Aho, I., Anand, A. C., Andersson, M. I., Arendt, V., Baatarkhuu, O., Barclay, K., Ben-Ari, Z., Bergin, C., Bessone, F., Blach, S., ... Gower, E. (2015). Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2. Journal of Viral Hepatitis, 22(s1), 6-25. https://doi.org/10.1111/jvh.12350

@article{2813877fdfa149a1a553566e20d89fc1,

title = "Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2",

abstract = "Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13\% in the Netherlands to 2.91\% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.",

keywords = "HCV, diagnosis, disease burden, epidemiology, hepatitis C, incidence, mortality, prevalence, treatment",

author = "V. Saraswat and S. Norris and \{De Knegt\}, \{R. J.\} and \{Sanchez Avila\}, \{J. F.\} and M. Sonderup and E. Zuckerman and P. Arkkila and C. Stedman and S. Acharya and I. Aho and Anand, \{A. C.\} and Andersson, \{M. I.\} and V. Arendt and O. Baatarkhuu and K. Barclay and Z. Ben-Ari and C. Bergin and F. Bessone and S. Blach and N. Blokhina and Brunton, \{C. R.\} and G. Choudhuri and V. Chulanov and L. Cisneros and Croes, \{E. A.\} and Dahgwahdorj, \{Y. A.\} and O. Dalgard and Daruich, \{J. R.\} and Dashdorj, \{N. R.\} and D. Davaadorj and \{De Vree\}, M. and C. Estes and R. Flisiak and Gadano, \{A. C.\} and E. Gane and W. Halota and A. Hatzakis and C. Henderson and P. Hoffmann and J. Hornell and D. Houlihan and S. Hrusovsky and P. Jar{\v c}u{\v s}ka and D. Kershenobich and K. Kostrzewska and P. Kristian and M. Leshno and Y. Lurie and A. Mahomed and N. Mamonova and N. Mendez-Sanchez and J. Mossong and E. Nurmukhametova and P. Nymadawa and M. Oltman and J. Oyunbileg and Ts Oyunsuren and G. Papatheodoridis and N. Pimenov and N. Prabdial-Sing and M. Prins and P. Puri and S. Radke and A. Rakhmanova and H. Razavi and K. Razavi-Shearer and Reesink, \{H. W.\} and E. Ridruejo and R. Safadi and O. Sagalova and R. Sanduijav and I. Schr{\'e}ter and C. Seguin-Devaux and Shah, \{S. R.\} and I. Shestakova and A. Shevaldin and O. Shibolet and S. Sokolov and K. Souliotis and Spearman, \{C. W.\} and T. Staub and Strebkova, \{E. A.\} and D. Struck and K. Tomasiewicz and L. Undram and \{Van Der Meer\}, \{A. J.\} and \{Van Santen\}, D. and I. Veldhuijzen and Villamil, \{F. G.\} and S. Willemse and Zuure, \{F. R.\} and Silva, \{M. O.\} and V. Sypsa and E. Gower",

note = "Publisher Copyright: {\textcopyright} 2014 John Wiley \& Sons Ltd.",

year = "2015",

month = jan,

day = "1",

doi = "10.1111/jvh.12350",

language = "אנגלית",

volume = "22",

pages = "6--25",

journal = "Journal of Viral Hepatitis",

issn = "1352-0504",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "s1",

}

Saraswat, V, Norris, S, De Knegt, RJ, Sanchez Avila, JF, Sonderup, M, Zuckerman, E, Arkkila, P, Stedman, C, Acharya, S, Aho, I, Anand, AC, Andersson, MI, Arendt, V, Baatarkhuu, O, Barclay, K, Ben-Ari, Z, Bergin, C, Bessone, F, Blach, S, Blokhina, N, Brunton, CR, Choudhuri, G, Chulanov, V, Cisneros, L, Croes, EA, Dahgwahdorj, YA, Dalgard, O, Daruich, JR, Dashdorj, NR, Davaadorj, D, De Vree, M, Estes, C, Flisiak, R, Gadano, AC, Gane, E, Halota, W, Hatzakis, A, Henderson, C, Hoffmann, P, Hornell, J, Houlihan, D, Hrusovsky, S, Jarčuška, P, Kershenobich, D, Kostrzewska, K, Kristian, P, Leshno, M, Lurie, Y, Mahomed, A, Mamonova, N, Mendez-Sanchez, N, Mossong, J, Nurmukhametova, E, Nymadawa, P, Oltman, M, Oyunbileg, J, Oyunsuren, T, Papatheodoridis, G, Pimenov, N, Prabdial-Sing, N, Prins, M, Puri, P, Radke, S, Rakhmanova, A, Razavi, H, Razavi-Shearer, K, Reesink, HW, Ridruejo, E, Safadi, R, Sagalova, O, Sanduijav, R, Schréter, I, Seguin-Devaux, C, Shah, SR, Shestakova, I, Shevaldin, A, Shibolet, O, Sokolov, S, Souliotis, K, Spearman, CW, Staub, T, Strebkova, EA, Struck, D, Tomasiewicz, K, Undram, L, Van Der Meer, AJ, Van Santen, D, Veldhuijzen, I, Villamil, FG, Willemse, S, Zuure, FR, Silva, MO, Sypsa, V & Gower, E 2015, 'Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2', Journal of Viral Hepatitis, vol. 22, no. s1, pp. 6-25. https://doi.org/10.1111/jvh.12350

TY - JOUR

T1 - Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

AU - Saraswat, V.

AU - Norris, S.

AU - De Knegt, R. J.

AU - Sanchez Avila, J. F.

AU - Sonderup, M.

AU - Zuckerman, E.

AU - Arkkila, P.

AU - Stedman, C.

AU - Acharya, S.

AU - Aho, I.

AU - Anand, A. C.

AU - Andersson, M. I.

AU - Arendt, V.

AU - Baatarkhuu, O.

AU - Barclay, K.

AU - Ben-Ari, Z.

AU - Bergin, C.

AU - Bessone, F.

AU - Blach, S.

AU - Blokhina, N.

AU - Brunton, C. R.

AU - Choudhuri, G.

AU - Chulanov, V.

AU - Cisneros, L.

AU - Croes, E. A.

AU - Dahgwahdorj, Y. A.

AU - Dalgard, O.

AU - Daruich, J. R.

AU - Dashdorj, N. R.

AU - Davaadorj, D.

AU - De Vree, M.

AU - Estes, C.

AU - Flisiak, R.

AU - Gadano, A. C.

AU - Gane, E.

AU - Halota, W.

AU - Hatzakis, A.

AU - Henderson, C.

AU - Hoffmann, P.

AU - Hornell, J.

AU - Houlihan, D.

AU - Hrusovsky, S.

AU - Jarčuška, P.

AU - Kershenobich, D.

AU - Kostrzewska, K.

AU - Kristian, P.

AU - Leshno, M.

AU - Lurie, Y.

AU - Mahomed, A.

AU - Mamonova, N.

AU - Mendez-Sanchez, N.

AU - Mossong, J.

AU - Nurmukhametova, E.

AU - Nymadawa, P.

AU - Oltman, M.

AU - Oyunbileg, J.

AU - Oyunsuren, Ts

AU - Papatheodoridis, G.

AU - Pimenov, N.

AU - Prabdial-Sing, N.

AU - Prins, M.

AU - Puri, P.

AU - Radke, S.

AU - Rakhmanova, A.

AU - Razavi, H.

AU - Razavi-Shearer, K.

AU - Reesink, H. W.

AU - Ridruejo, E.

AU - Safadi, R.

AU - Sagalova, O.

AU - Sanduijav, R.

AU - Schréter, I.

AU - Seguin-Devaux, C.

AU - Shah, S. R.

AU - Shestakova, I.

AU - Shevaldin, A.

AU - Shibolet, O.

AU - Sokolov, S.

AU - Souliotis, K.

AU - Spearman, C. W.

AU - Staub, T.

AU - Strebkova, E. A.

AU - Struck, D.

AU - Tomasiewicz, K.

AU - Undram, L.

AU - Van Der Meer, A. J.

AU - Van Santen, D.

AU - Veldhuijzen, I.

AU - Villamil, F. G.

AU - Willemse, S.

AU - Zuure, F. R.

AU - Silva, M. O.

AU - Sypsa, V.

AU - Gower, E.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.

AB - Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.

KW - HCV

KW - diagnosis

KW - disease burden

KW - epidemiology

KW - hepatitis C

KW - incidence

KW - mortality

KW - prevalence

KW - treatment

UR - https://www.scopus.com/pages/publications/84920274258

U2 - 10.1111/jvh.12350

DO - 10.1111/jvh.12350

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:84920274258

SN - 1352-0504

VL - 22

SP - 6

EP - 25

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

IS - s1

ER -

Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this